Axcel Fusidic Acid-B Dosage & Drug Information

Concise Prescribing Info

Contents

Fusidic acid 2%, betamethasone 17-valerate 0.1%

Indications/Uses

Inflammatory dermatoses where bacterial infection is present or likely to occur eg, atopic eczema, discoid eczema, stasis eczema, seborrhoeic dermatitis, contact dermatitis, lichen simplex chronicus, psoriasis, discoid lupus erythematosus.

Dosage/Direction for Use

Apply bd-tds.

Contraindications

Viral skin diseases, bacterial infection, perioral dermatitis, acne rosacea, fungal skin infection, ulcerative conditions, application to eye.

Special Precautions

Broken skin, prolonged use, under occlusive dressings. Pregnancy & lactation. Not to be used for >3 wk in infant & childn ≤4 yr.

Adverse Reactions

Loss of skin collagen & subcutaneous atrophy eg, striae, thinning & dilation of superficial blood vessels.

View ADR Monitoring Form

MIMS Class

Topical Anti-Infectives with Corticosteroids

ATC Classification

D07BC01 - betamethasone and antiseptics ; Belongs to the class of potent (group III) corticosteroids, in combination with antiseptics. Used in the treatment of dermatological diseases.

Regulatory Classification

Presentation/Packing

Form

Axcel Fusidic Acid-B cream

Packing/Price

15 g x 1's;5 g x 1's

Axcel Fusidic Acid-B

betamethasone + fusidic acid

Manufacturer:

Kotra Pharma

Distributor:

Kotra Pharma